This is never a very interesting comment. Older styles of insulin that no one wants to use are dirt cheap. The newer and preferred kind is still under patent, and one can quibble about that but it was very expensive to develop and Eli Lilly & Co. just announced a monthly out of pocket price cap of $35. Other countries have different systems that cap prices, so pharmas try to take profits in the US. It's not a very good system, but it has produced a lot of really impressive drugs in the last 50 years. We can do better of course, but trashing any medical advance with a quip about insulin is just childish and boring.

I agree that selecting an embryo will become inexpensive.

However, the game will be to select the "best" embryo. This becomes a game of numbers where, on average, the quality of the embryo will be a function of the size the pool of embryos and this will be a function of how much the future parents spend.